Nova EYE Medical Ltd
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degen… Read more
Nova EYE Medical Ltd - Asset Resilience Ratio
Nova EYE Medical Ltd (EYE) has an Asset Resilience Ratio of 19.07% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2001–2025)
This chart shows how Nova EYE Medical Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Nova EYE Medical Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$5.05 Million | 19.07% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$5.05 Million | 19.07% |
Asset Resilience Insights
- Good Liquidity Position: Nova EYE Medical Ltd maintains a healthy 19.07% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Nova EYE Medical Ltd Industry Peers by Asset Resilience Ratio
Compare Nova EYE Medical Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Nova EYE Medical Ltd (2001–2025)
The table below shows the annual Asset Resilience Ratio data for Nova EYE Medical Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 19.07% | AU$5.05 Million | AU$26.50 Million | -1.51pp |
| 2024-06-30 | 20.58% | AU$6.15 Million | AU$29.88 Million | -3.85pp |
| 2023-06-30 | 24.44% | AU$7.42 Million | AU$30.36 Million | +2.60pp |
| 2022-06-30 | 21.84% | AU$8.00 Million | AU$36.62 Million | -20.55pp |
| 2021-06-30 | 42.39% | AU$17.80 Million | AU$41.99 Million | -39.54pp |
| 2020-06-30 | 81.93% | AU$95.65 Million | AU$116.74 Million | +66.54pp |
| 2019-06-30 | 15.39% | AU$15.37 Million | AU$99.89 Million | -6.91pp |
| 2018-06-30 | 22.29% | AU$23.07 Million | AU$103.47 Million | +11.61pp |
| 2017-06-30 | 10.68% | AU$9.24 Million | AU$86.54 Million | +10.30pp |
| 2008-06-30 | 0.38% | AU$275.00K | AU$71.94 Million | +0.12pp |
| 2007-06-30 | 0.26% | AU$167.00K | AU$63.69 Million | +0.16pp |
| 2006-06-30 | 0.10% | AU$46.00K | AU$46.48 Million | -42.45pp |
| 2001-06-30 | 42.54% | AU$487.42K | AU$1.15 Million | -- |